Cargando…
Transglutaminase 2 as a Marker for Inflammation and Therapeutic Target in Sepsis
Sepsis results in lethal organ malfunction due to dysregulated host response to infection, which is a condition with increasing prevalence worldwide. Transglutaminase 2 (TG2) is a crosslinking enzyme that forms a covalent bond between lysine and glutamine. TG2 plays important roles in diverse cellul...
Autores principales: | Su, Ting, Qin, Xian-Yang, Furutani, Yutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918628/ https://www.ncbi.nlm.nih.gov/pubmed/33672962 http://dx.doi.org/10.3390/ijms22041897 |
Ejemplares similares
-
Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid
por: Qin, Xian-Yang, et al.
Publicado: (2023) -
Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death
por: Tatsukawa, H, et al.
Publicado: (2016) -
Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase
por: Liu, Chen, et al.
Publicado: (2017) -
A Novel Therapeutic Target in Inflammatory Uveitis: Transglutaminase 2 Inhibitor
por: Sohn, Joonhong, et al.
Publicado: (2010) -
Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies
por: Zhang, Jie, et al.
Publicado: (2021)